盆腔冲洗液中残留癌细胞的准确定量揭示其与机器人辅助根治性膀胱切除术后癌症复发的关联
本研究对17例接受机器人辅助根治性膀胱切除术的患者术中采集盆腔冲洗液和血液,采用全外显子组测序联合超深度靶向测序(深度大于50,000×)定量残留癌细胞,最终9例纳入分析。约半数冲洗液标本在术中或术后检测到残留癌细胞,较高残留癌细胞水平与侵袭性变异组织学及癌症复发相关。作者认为术中腹膜冲洗液残留癌细胞可能成为肿瘤侵袭性和转移潜能的生物标志物,但验证其可行性需更大队列。
要点
- 机器人辅助根治性膀胱切除术中或术后约半数盆腔冲洗液标本可检测到残留癌细胞。
- 较高残留癌细胞水平与侵袭性变异组织学及癌症复发相关。
- 作者认为残留癌细胞可能成为肿瘤侵袭性和转移潜能的生物标志物,验证可行性需更大队列。
核心结论
- 根治性膀胱切除术患者术中腹膜冲洗液检测残留癌细胞可能代表肿瘤侵袭性和转移潜能的稳健生物标志物。
- 验证残留癌细胞作为复发新型生物标志物的可行性需要更大队列。
研究设计与样本
- 研究纳入17例接受机器人辅助根治性膀胱切除术且手术切缘阴性的患者,原发肿瘤标本可获取。
- 术中在机器人辅助根治性膀胱切除术前后、盆腔淋巴结清扫后采集盆腔冲洗液和血液,并收集术中吸引液。
- 采用两步测序(全外显子组测序后超深度靶向测序,深度大于50,000×)定量各样本残留癌细胞。
- 8例因样本质量问题被排除,最终分析队列为9例。
主要发现
- 约半数盆腔冲洗液标本在机器人辅助根治性膀胱切除术术中或术后检测到残留癌细胞,术前未检测到。
- 较高残留癌细胞水平与侵袭性变异组织学及癌症复发相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 8例因样本质量问题被排除,最终分析队列仅9例。
- 验证残留癌细胞作为复发新型生物标志物的可行性需要更大队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Bladder cancer recurrence following cystectomy remains a significant cause of bladder cancer specific mortality. Residual cancer cells contribute to cancer recurrence due to tumor spillage or undetectable preexisting micrometastatic tumor clones. We detected and quantified residual cancer cells in pelvic washing using ultradeep targeted sequencing. We compared the levels of residual cancer cells with clinical variables and cancer recurrence. MATERIALS AND METHODS: The primary tumor specimen was available in 17 patients who underwent robot-assisted radical cystectomy. All tumors had negative surgical margins. Pelvic washes and blood were collected intraoperatively before and after robot-assisted radical cystectomy, after pelvic lymph node dissection and in the suction fluid collected during the procedure. Two-step sequencing, including whole exome sequencing followed by ultradeep targeted sequencing (× greater than 50,000), was done to quantify residual cancer cells in each sample. Eight patients were excluded from study due to sample quality issues. The final analysis cohort comprised 9 patients. The residual cancer cell level was quantified for each sample as the relative cancer cell fraction and compared between time points. The peak relative cancer cell fraction of each patient was correlated with clinical and pathological variables. RESULTS: Residual cancer cells were detected in approximately half of the pelvic washing specimens during or after but not before robot-assisted radical cystectomy. Higher residual cancer cell levels were associated with aggressive variant histology and cancer recurrence. Verifying the feasibility of using residual cancer cells as a novel biomarker for recurrence requires larger cohorts. CONCLUSIONS: Detection of residual cancer cells in intraoperative peritoneal washes of patients with bladder cancer who undergo radical cystectomy may represent a robust biomarker of tumor aggressiveness and metastatic potential.
引用
- Wei L, Hussein AA, Ma Y, et al. Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy. J Urol. 2019. PMID: 30730413. doi:10.1097/JU.0000000000000142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。